MedTrace Logo

Bioavailability of PRUVIN® and Its Effects in Healthy Subjects (INDIGO)

NCT05041179 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2024-10-22

No results posted yet for this study

Summary

To evaluate the effect of different doses of PRUVIN® (N-acetylcysteine \[NAC\] and glycine) on reduced glutathione levels in healthy elderly subjects

Conditions

  • Oxidative Stress

Interventions

DIETARY_SUPPLEMENT

Pruvin R

Combination of N-acetylcysteine an glycine

OTHER

Isomaltulose

Placebo as comparator to intervention

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Ulrike Hövelmann, MD · Profil Institut für Stoffwechselforschung GmbH

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-04-01
Completion
2020-05-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05041179 on ClinicalTrials.gov